Introduction
Polycystic ovary syndrome (PCOS) is an etiologically heterogeneous condition which involves overproduction of ovarian androgens leading to a variable range of symptoms including hirsutism, acne, and anovulation. 1 Ovarian morphology, especially the ovarian size / ovarian volume (OV) and number of pre-antral follicles, is the key and consistent feature of polycystic ovaries. There might be ethnic differences in the ovarian dimensions or morphology used to define PCOS among different populations.
OV and follicle number (FN) also decrease with age, with the age-related decrease in FN seemingly greater than that of OV. 1) the presence of ≥ 12 follicles in each ovary measuring 2 to 9 mm in diameter; and/or 2) increased OV (> 10 mL).
Exclusion criteria for this study were as follows: a history of ovarian surgery; hormonal treatment in the previous 3 months or PCOS-related treatment before this research;
and an ovarian mass or cyst (more than 10 mm in diameter)
detected by ultrasound examination in this study. Age, parity, and body mass index (BMI) of all cases were recorded.
Measurement of antral follicle count and OV
by US All PCOS subjects in Korea were examined by a single examiner (KMJ), and participants were evaluated by transrectal and transvaginal US according to their sexual activity.
Ultrasound examination was performed in all participants with Voluson S7 (General Electric Systems, Seongnam, Korea) equipped with a 7-MHz transvaginal transducer.
For each ovary, the total number of visible antral follicles measuring 2 to 9 mm in diameter was counted by continuous scanning of the entire ovary, from the inner margin to the outer margin in longitudinal cross-section.
The OV was calculated using the simplified formula for a prolate ellipsoid (0.5 × length × width × thickness). 7 FN was established by scanning each ovary from the inner margin to the outer margin in longitudinal cross-section and obtaining the number of all countable follicles.
Hormone assay
Blood samples were drawn for the determination of serum levels of total testosterone, free testosterone, androstenedione and dehydroepiandrosterone-sulfate (DHEA-S). The serum AMH level was measured using the AMH Gen II assay (Beckman Coulter Inc., Brea, CA, USA).
Statistical analysis
All the data were analyzed on a personal computer using the SPSS 13.0 for Windows statistical package (SPSS Inc., Chicago, IL, USA). The data are presented as proportion and mean ± standard deviation (SD). The Kruskal-Wallis test confirmed that the data were not normally distributed (and are presented as mean ± SD), and hence, the Student' s t-test was used to compare the differences between the groups.
Spearman' s correlation was used to analyze the relationship between hormone assay and OV, and FN.
Results
All target groups included young women who were premenopausal without the experience of delivery, and their average age was 23.6 ± 5.3 years. Women aged 20 to 29 There was no effect on bilateral OV according to age and BMI, and ovarian FN was not affected by BMI. However, left ovarian FN was significantly decreased (P = 0.0343) with increasing age. In all women included in our study, the right OV was significantly larger than the left OV (P < 0.0001; Table 2 ).
In our study, the average AMH level was 13.9 ± 7.2 ng/ mL, total testosterone level was 66.2 ± 35.6 ng/dL, free (Table 4) . Kelsey et al. 9 studied that in the average case OV rises from 0.7 mL (95% CI: 0.4-1.1 mL) at 2 years of age to a peak of 7.7 mL (95% CI: 6.5-9.2 mL) at 20 years of age with a subsequent decline to about 2.8 mL (95% CI: 2.7-2.9 mL) at the menopause and smaller volumes thereafter.
Alsamarai et al. 10 concluded that OV and FN decrease with age in women with PCOS. Christensen et al. 11 found that OV was not related to age in 428 healthy women aged between 18 and 45 years. In Chinese study 12 , they found a moderate negative correlation of age with OV, suggesting that there are no major changes in OV during reproductive ages until the perimenopause. In our study, we could not identify any relationship between age and OV in the PCOS group. This may be due to selection of nulliparous women under 40 years in the study.
Mean OV was statistically larger in PCOS patients than in the control group, but there was no significant difference between the non-obese and obese women with PCOS. 13 In our study, there was no difference between OV, ovarian FN and weight, height, and BMI, and this result was due to the inclusion of young nulliparous women.
The threshold for distinguishing polycystic ovaries from normal ovaries varied from 8 to 17.6 cm 3 among different studies. 14~16 The main reason for this may be the difference in methods used to determine the OV, or difference in ethnicity. There is also some controversy about the use of FN as an ultrasound predictor of PCOS. But most studies that use FN for the diagnosis of PCOS have set the threshold at 10. 14 In our Korean women with PCOS, the right OV was 7.9 ± 3.6 cm 3 and the left OV was 6.7 ± AMH is regarded as the most useful marker of the status of ovarian reserve, 18 and a highly significant relationship between the serum AMH level and ovarian FN on US was reported in numerous studies. 3, 6, 19 The pathogenesis of PCOS has been cased mainly to disordered folliculogenesis causing oligo-ovulatory cycles or impaired folliculogenesis with increased preantral and small antral follicle counts, which resulted in high serum AMH levels. 20 Although several cutoff values of AMH have been proposed, the optimal threshold remains unclear due to varying sensitivity and specificity. In There is a good correlation between AMH levels and the number of small follicles as well as OV. The level of AMH is higher in patients with PCOS, which can be helpful in the diagnosis of this syndrome. 20, 21 Due to the use of various methods to analyze plasma AMH levels, it is difficult to compare previous studies and specify diagnostic norms that would be characterized by high sensitivity and specificity for patients with the features of PCO. 18, 20 The serum AMH levels were also positively associated with testosterone levels and OV.
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that testosterone is the most sensitive androgen measurement and it is often measured when conducting clinical research studies in women with PCOS. 23 Larger
OVs and FNs correlated with higher serum testosterone and androstenedione levels and these suggest that FN on ultrasound and related OV are associated with hyperandrogenic state in women with PCOS.
In our study, the average serum level of total testosterone was 66.2 ± 35.6 ng/dL, free testosterone level was estimated to be 1.3 ± 0.8 ng/dL, mean OV was 7.9 ± 3.6 cm 3 (Rt.), 6.7 ± 3.1 cm 3 (Lt.), and follicle count was 14.2 ± 4.6. As a result of the AMH test, mean serum density was 13.9 ± 7.2 ng/mL and these results correlated with Welt' s study. 3 Our study attempted to provide Korean PCOS data on AMH and to establish the relevance between AMH and clinical and biochemical characteristics of PCOS, and serum AMH level was related to both total testosterone and ovarian morphology under sonography.
The measurement of AMH is an important marker of ovarian ageing, but it has not been shown to be helpful in assessing ovarian reserve in the individual.
The present study has limitations that mostly stem from its retrospective study design and a relatively small sample size and nulliparous women without experience of pregnancy.
In conclusion, our study showed that the serum AMH was significantly correlated with the OV and total testosterone and the serum AMH level were related to the ovarian FN in Korean women with PCOS. These results suggest that serum total testosterone and AMH are more useful to represent the status of the OV and FN in women with PCOS. Also, ovarian FN is a more important diagnostic predictor in the diagnosis of PCOS in Korean women.
Further prospective large-scale trials are needed to confirm this preliminary finding.
